Toggle navigation
Home
Search
Services
Blog
Contact
About
TB Center Grant
Temesgen, Zelalem
Mayo Clinic, Rochester, Rochester, MN, United States
Search 11 grants from Zelalem Temesgen
Search grants from Mayo Clinic, Rochester
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Cardiac biomarkers and risk of heart failure and progression of kidney disease in patients with chronic kidney disease
KL4 Surfactant to Mitigate Radiation-Induced Lung Injury
Cancer Biology and Biotechnology Research Program
Estrogen: Neuroprotection in the Perimenopause
Narcolepsy - Multicenter Genetic and Family Study
Recently added grants:
Programs of Gene Expression in Olfactory Neurogenesis
Anti-oxidant and Metabolic Phenotype in Regulating Tumor Specific T cell Memory Response
Regulation of Intrinsic Plasticity in Neural Circuits
Mechanisms of force sensing in the nervous system
Combination treatment of ischemic stroke with perlecan DV and neural stem cells
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Center for HIV, Viral Hepatitis, STDS and Tb Prevention (NCHHSTP)
Type
Cooperative Agreement for Tuberculosis Control (U52)
Project #
5U52PS004096-02
Application #
8585791
Study Section
Special Emphasis Panel (ZPS1-SRC (99))
Project Start
2013-01-01
Project End
2017-12-31
Budget Start
2014-01-01
Budget End
2014-12-31
Support Year
2
Fiscal Year
2014
Total Cost
$536,474
Indirect Cost
$39,739
Institution
Name
Mayo Clinic, Rochester
Department
Type
DUNS #
006471700
City
Rochester
State
MN
Country
United States
Zip Code
55905
Related projects
NIH 2015
U52 PS
TB Center Grant
Temesgen, Zelalem / Mayo Clinic, Rochester
NIH 2014
U52 PS
TB Center Grant
Temesgen, Zelalem / Mayo Clinic, Rochester
$536,474
NIH 2013
U52 PS
TB Center Grant
Temesgen, Zelalem / Mayo Clinic, Rochester
$1,072,947
Comments
Be the first to comment on Zelalem Temesgen's grant